136 related articles for article (PubMed ID: 31186172)
1. Re: Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019;76:340-51.
Park BK
Eur Urol; 2019 Sep; 76(3):e78. PubMed ID: 31186172
[No Abstract] [Full Text] [Related]
2. Reply to Byung Kwan Park's Letter to the Editor re: Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019;76:329-40.
Rosenkrantz AB; Turkbey B; Barentsz J; Weinreb JC
Eur Urol; 2019 Sep; 76(3):e79. PubMed ID: 31182228
[No Abstract] [Full Text] [Related]
3. Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.
Giganti F; Dickinson L; Allen C; Moore CM
Eur Urol Oncol; 2024 Apr; 7(2):308. PubMed ID: 37722978
[No Abstract] [Full Text] [Related]
4. Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
Rud E; Baco E
Eur Urol; 2016 Nov; 70(5):e136. PubMed ID: 27126376
[No Abstract] [Full Text] [Related]
5. Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40.
Barentsz JO; Choyke PL; Cornud F; Haider MA; Macura KJ; Margolis D; Shtern F; Padhani AR; Tempany CM; Thoeny HC; Verma S; Weinreb JC
Eur Urol; 2016 Nov; 70(5):e137-e138. PubMed ID: 27130148
[No Abstract] [Full Text] [Related]
6. Re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491-502.
Anand M; Jain B; Aggarwal S
Eur Urol; 2024 May; 85(5):e145. PubMed ID: 38092614
[No Abstract] [Full Text] [Related]
7. Reply to Madhur Anand, Bela Jain, and Swati Aggarwal's Letter to the Editor re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-Specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491-502.
Hartrampf PE; Rowe SP; Pomper MG; Higuchi T; Gorin MA; Werner RA
Eur Urol; 2024 May; 85(5):e146-e147. PubMed ID: 38087733
[No Abstract] [Full Text] [Related]
8. Re: Farnoosh Nik-Ahd, Andrew Jarjour, Jane Figueiredo, et al. Prostate-specific Antigen Screening in Transgender Patients. Eur Urol. 2023;83:48-54.
García Nader S; Peña Rodríguez S; Diaz Ritter CA
Eur Urol; 2023 Apr; 83(4):e103. PubMed ID: 36610879
[No Abstract] [Full Text] [Related]
9. Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 2012;61:443-51.
Ghadjar P; Aebersold DM
Eur Urol; 2012 Apr; 61(4):e39. PubMed ID: 22169076
[No Abstract] [Full Text] [Related]
10. Re: Andrew Vickers, Caroline Bennette, Gunnar Steineck, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol 2012;62:204-9.
Froehner M; P Wirth M
Eur Urol; 2012 Sep; 62(3):e53; author reply e54. PubMed ID: 22727175
[No Abstract] [Full Text] [Related]
11. Re: Marloes van der Leest, Bas Israël, Eric Bastiaan Cornel, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol 2019;76:574-81: Are We Meeting Our Standards? Stringent Prostate Imaging Reporting and Data System Acquisition Requirements Might Be Limiting Prostate Accessibility.
Stanzione A; Imbriaco M; Cuocolo R
Eur Urol; 2020 Mar; 77(3):e56-e57. PubMed ID: 31787427
[No Abstract] [Full Text] [Related]
12. Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6. Eur Urol 2015;68:e7-8.
Autorino R; Zargar H; Porpiglia F
Eur Urol; 2015 Jul; 68(1):e9-10. PubMed ID: 25666848
[No Abstract] [Full Text] [Related]
13. Re: Andrew Erickson, Alicia Hayes, Timothy Rajakumar, et al. A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease. Eur Urol Oncol 2021;4:358-69.
Kneppers J; de Barros H; van der Poel H
Eur Urol Oncol; 2021 Oct; 4(5):851. PubMed ID: 34535422
[No Abstract] [Full Text] [Related]
14. Re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11.
Wei Y; Zhu Y; Ye D
Eur Urol; 2022 Jul; 82(1):e14. PubMed ID: 35393161
[No Abstract] [Full Text] [Related]
15. Re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis. Eur Urol 2017;72:177-88.
Ayubi E; Safiri S
Eur Urol; 2018 Feb; 73(2):e29. PubMed ID: 28801125
[No Abstract] [Full Text] [Related]
16. Re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8.
Froehner M
Eur Urol; 2014 Mar; 65(3):e41. PubMed ID: 24315704
[No Abstract] [Full Text] [Related]
17. Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9.
Shen Y; Ye D
Eur Urol; 2012 Feb; 61(2):e3; author reply e4-5. PubMed ID: 21824719
[No Abstract] [Full Text] [Related]
18. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: Sungmin Woo, Chong Hyun Suh, Sang Youn Kim, Jeong Yeon Cho, Seung Hyup Kim. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis. Eur Urol 2017;72:177-88.
Woo S; Suh CH; Kim SY
Eur Urol; 2018 Feb; 73(2):e30. PubMed ID: 28807349
[No Abstract] [Full Text] [Related]
19. Re: M. Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013;64:713-9 and Re: Mark Emberton. Has magnetic resonance-guided biopsy of the prostate become the standard of care? Eur Urol 2013;64:720-1.
van den Bergh RC; van der Poel HG
Eur Urol; 2014 Jun; 65(6):e106-7. PubMed ID: 24411989
[No Abstract] [Full Text] [Related]
20. Reply to Michael Froehner's letter to the editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol 2013;64:372-8.
Nepple KG; Kibel AS
Eur Urol; 2014 Mar; 65(3):e42. PubMed ID: 24315707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
